What is the experience with sertindole in clinical practice?

International Journal of Psychiatry in Clinical Practice

Volumn 2, Issue SUPPL. 2, 1998, Pages

  Perquin, Lowijs ^a,b   Wesselius, Jessica ^a   Kempe, Pieter ^a   Halkema, Reen ^a  

^a Valeriuskliniek   (Netherlands)

^b Valeriuskliniek   (Netherlands)

Author keywords

Compliance; Schizophrenia; Sertindole; Side effects; Switching therapy

Indexed keywords

SERTINDOLE;

ADULT; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NOSE CONGESTION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 0032410397     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-30.
2. Tamminga CA, Buchanan RW, Gold JM (1998) The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 13 (suppl 3): S21-6.
3. Goldberg TE, Kelsoe JR, Weinberg DR et al (1988) Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function. Int J Neurosci 42: 51-8.
4. Barnes TRE, McPhillips MA (1998) Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol 13 (suppl 3): S49-S57.
5. van Harten PN, Matroos GE, Hoek HW, Kahn RS (1996) The prevalence of tardive dystonia, tardive dyskinesia, Parkinsonism and akathisia: the Curacao Extrapyramidal Syndromes Study I. Schizophr Res 19: 196-203.
6. Kane JM, Jeste DV, Barnes TRE et al (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. American Psychiatric Association, Washington DC.
7. Barnes TRE (1992) Clinical assessment of the extrapyramidal side effects of antipsychotic drugs. J Psychopharmacol 6: 214-21.
8. Casey DE (1996) Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57 (suppl 11): 40-5.
9. van Harten PN, Hoek HW, Matroos GE et al (1998) Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curacao Extrapyramidal Syndromes Study III. Am J Psychiatry 155: 565-7.
10. Zimbroff D, Kane JM, Tamminga CA et al (1997) A controlled, dose-response study of sertindole and haloperidol in schizophrenia. Am J Psychiatry 154: 782-91.
11. Hale A, van der Burght M, Wehnert A (1996) A European dose-range study comparing the efficacy, tolerability and safety of four doses of sertindole and one dose of haloperidol in schizophrenic patients [abstract]. In: 20th Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), Melbourne, Australia, 23-27 June, 1996. CINP, Montreal.
12. van Kammen DP, McEvoy JP, Targum SD et al (1996) A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology 124: 168-75.
13. Wirshing DA, Marder SR, Goldstein D, Wirshing WC (1997) Novel antipsychotics: comparison of weight gain liabilities, [abstract]. In: 36th American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December 8-12, 1997, p. 184. American College of Neuropsychopharmacology, Nashville TN.
14. Hale AS (1998) A review of the safety and tolerability of sertindole. Int Clin Psychopharmacol 13 (suppl 3): S65-70.
15. Kay SR, Fisbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-76.
16. Overall JE, Gorham DR (1976) BPRS, Brief Psychiatric Rating Scale. In: Guy W, (ed.): ECDEU Assessment Manual for Psychopharmacology, 157-69. National Institute of Mental Health, Rockville, MD.
17. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-9.
18. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health and Human Services publication (ADM) 338: 534-5.
19. Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Pharmacol 154: 672-6.
20. Burke RE, Fahn S, Marsden CD et al (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35: 73-7.
21. Peuskens J (1998) Good medical practice in antipsychotic pharmacotherapy. Int Clin Psychopharmacol 13 (suppl 3): S35-41.